Ehlers-Danlos syndrome hypermobility type is associated with rheumatic diseases.

Autoimmune neuropathies associated to rheumatic diseases

Autoimmun Rev.

Martinez AR, Faber I, Nucci A, Appenzeller S, França MC Jr

doi: 10.1016/j.autrev.2017.02.003.

Osteoarthritis

Metabolic syndrome-associated osteoarthritis.

Curr Opin Rheumatol.

Courties A, Sellam J, Berenbaum F

doi: 10.1097/

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Ann Rheum Dis.

Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC, COVID-19 Global Rheumatology Alliance.

doi: 10.1136/annrheumdis-2020-217871.

EULAR ^® 2019

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Rheumatic and Musculoskeletal Diseases

Yusof et al. 2019. Predicting severe infection in repeat cycles of rituximab and effects of hypogammaglobulinemia for the treatment of rheumatic and musculoskeletal diseases. Oral presentation presented at: EULAR 2019 Congress; 12–15 June 2019; Madrid, Spain.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis

Arthritis Rheumatol.

Wallace ZS, Fu X, Liao K, Kallenberg CGM, Langford CA, Merkel PA, Monach P, Seo P, Specks U, Spiera R, St Clair EW, Zhang Y, Choi H, Stone JH

doi: 10.1002/art.41006.

Autoimmune Disease

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs

Rheumatology (Oxford).

Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A

doi: 10.1093/rheumatology/keaa078.

Systemic Lupus Erythematosus

Therapeutic plasma exchange in rheumatic diseases: a university hospital experience.

Rev Bras Reumatol.

Córdoba JP, Larrarte C, Estrada C, Fernández-Ávila DG

doi: 10.1016/j.rbr.2016.11.003.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Semin Arthritis Rheum.

Michelena X, Borrell H, López-Corbeto M, López-Lasanta M, Moreno E, Pascual-Pastor M, Erra A, Serrat M, Espartal E, Antón S, Añez GA, Caparrós-Ruiz R, Pluma A, Trallero-Araguás E, Barceló-Bru M, Almirall M, De Agustín JJ, Segura JL, Julià A, Marsal S

doi: 10.1016/j.semarthrit.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Ann Rheum Dis.

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I

doi: 10.1136/annrheumdis-2020-217960.

Related content

Autoimmune neuropathies associated to rheumatic diseases

Metabolic syndrome-associated osteoarthritis.

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Rheumatic and Musculoskeletal Diseases

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs

Therapeutic plasma exchange in rheumatic diseases: a university hospital experience.

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort